Silk Road Medical Inc (NASDAQ: SILK) on Friday, soared 0.81% from the previous trading day, before settling in for the closing price of $27.28. Within the past 52 weeks, SILK’s price has moved between $6.08 and $27.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 40.27% over the last five years. The company achieved an average annual earnings per share of 1.30%. With a float of $38.08 million, this company’s outstanding shares have now reached $39.17 million.
The firm has a total of 474 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.28%, operating margin of -31.43%, and the pretax margin is -29.53%.
Silk Road Medical Inc (SILK) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Silk Road Medical Inc is 6.28%, while institutional ownership is 93.98%. The most recent insider transaction that took place on Aug 19 ’24, was worth 61,470. In this transaction EVP/Chief Legal Officer/Sec. of this company sold 2,268 shares at a rate of $27.10, taking the stock ownership to the 162,926 shares. Before that another transaction happened on Aug 19 ’24, when Company’s Officer proposed sale 2,268 for $27.10, making the entire transaction worth $61,469.
Silk Road Medical Inc (SILK) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 1.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.60% during the next five years compared to -3.21% drop over the previous five years of trading.
Silk Road Medical Inc (NASDAQ: SILK) Trading Performance Indicators
Silk Road Medical Inc (SILK) is currently performing well based on its current performance indicators. A quick ratio of 6.69 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Silk Road Medical Inc (SILK)
Analysing the last 5-days average volume posted by the [Silk Road Medical Inc, SILK], we can find that recorded value of 1.74 million was better than the volume posted last year of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 96.29%. Additionally, its Average True Range was 0.13.
During the past 100 days, Silk Road Medical Inc’s (SILK) raw stochastic average was set at 100.00%, which indicates a significant increase from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.82% in the past 14 days, which was lower than the 46.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.09, while its 200-day Moving Average is $19.76. Now, the first resistance to watch is $27.51. This is followed by the second major resistance level at $27.51. The third major resistance level sits at $27.53. If the price goes on to break the first support level at $27.49, it is likely to go to the next support level at $27.47. Now, if the price goes above the second support level, the third support stands at $27.47.
Silk Road Medical Inc (NASDAQ: SILK) Key Stats
Market capitalization of the company is 1.12 billion based on 39,444K outstanding shares. Right now, sales total 177,130 K and income totals -55,740 K. The company made 51,240 K in profit during its latest quarter, and -16,600 K in sales during its previous quarter.
